We analyzed the H-2 class-I expression of different clones obtained from 4 different methylcholanthrene-induced tumors in BALB/c (H-2d) mice. The results clearly indicated high intra-tumor heterogeneity in all 4 fibrosarcomas with regard t o H-2 K, D and L expression. Clones were found t o be H-2-negative. H-2-positive, or t o present intermediate expression. Southern blot analysis of class-I genes showed RFLPs equal t o those obtained from normal BALB/c DNA, ruling out rearrangements or gross deletions in the class-I genes of different tumors. However, Northern blot studies showed a straightforward relationship between class-I mRNA levels and H-2 expression. In vivo experiments demonstrated an inverse relationship between local growth and spontaneous metastasis, e.g., H-2-positive class-I clones produced high numbers of lung colonies but very poor local growth, and vice-versa. These results paralleled the N K sensitivity or resistance of the different clones. Crossprotection experiments showed that only clones coming from the same tumor were able t o protect against challenge with clones of the same neoplasia but not with clones from different chemically induced fibrosarcomas, indicating that a clone of a given tumor probably contained the same TATA. Finally, we compared the H-2, K, D and L expression and class-I mRNA levels of various metastatic colonies. Interestingly, another degree of heterogeneity was found: an H-2-negative clone (GR9.BP) gave rise t o H-2-negative (B9MP6) and H-2-positive (B9MP2) metastatic colonies.Methylcholanthrene-induced fibrosarcomas present individual unique tumor-associated transplantation antigens (TATA) (Prehn and Main, 1957; Basombrio, 1970; Lennox et ul., 1981). The behavior of such chemically induced tumors in syngeneic animals has been extensively studied (Old et al., 1962;Klein et al., 1960;Fortuna et al., 1990). However, few studies have compared the biological behavior, immune response and presence or absence of MHC class-I antigens at the clonal level (Schirrmacher et al., 1981;Ogata et al., 1986; PCrez er al., 1989). Current efforts in this area concentrate on establishing the contribution of specific MHC gene products to the process of tumor growth and metastasis.The regulation of anti-tumor immunity can be broadly classified into 2 major systems: adoptive and non-adoptive immunity. Adoptive immunity is acquired, and is mediated by antigen-specific T lymphocytes which lyse tumor cells upon recognition of the antigen in association with MHC products by the highly polymorphic, clonally distributed, heterodimeric T-cell receptor. Non-adoptive immunity is provided, at least in part, by a small sub-set of the heterogeneous population of lymphoid cells characterized by their ability to spontaneously lyse a variety of tumor, virus-infected and non-differentiated embryonic cells in a non-MHC-restricted fashion. Evidence is accumulating that different effector and regulatory T cells may be involved in the recognition of tumor cells, depending on changes in MHC glycoproteins; eit...